Viewing nowCombinationRoze K Tablet 10/20 mg
Rosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.

MFDS item code 202004562 · Approved 2020.06.23 · Insurance code 641806910
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication helps to lower elevated total cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol levels. It is primarily used in conjunction with dietary therapy, and is administered as an adjunct when diet alone is insufficient. This medication is particularly suitable for patients at high risk of atherosclerotic cardiovascular disease due to hypercholesterolemia, and it is important to identify and address any secondary causes that may affect lipid levels due to other medical conditions or medications. Regular lipid tests are recommended during treatment for monitoring effectiveness, and in cases of acute coronary events, lipid levels should be checked at hospitalization to initiate appropriate treatment. Overall, this medication is used to improve dyslipidemia and reduce the risk of atherosclerotic cardiovascular disease.
This medicine is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dosage range of this medicine is 10/5mg to 10/20mg daily. The recommended starting dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.
This medication has been rarely reported to cause rhabdomyolysis, which can lead to serious muscle damage, therefore, if symptoms such as muscle pain or weakness occur, patients should consult a physician immediately. In particular, if there are risk factors such as severe infections, hypotension, major surgery or trauma, severe metabolic disorders, it may be necessary to temporarily discontinue or stop using the medication. Patients who are allergic to any components of this medication, have active liver disease, unexplained increases in liver enzymes, muscle diseases, severely impaired kidney function, or are pregnant or breastfeeding should not take this medication. Additionally, special caution is necessary for patients with moderate kidney impairment at risk for myopathy, hypothyroidism, familial history of muscle diseases, alcoholism, or those on certain drug combinations when taking this medication. This medication contains lactose, therefore patients with lactose intolerance should not take it. Patients with liver function impairment or those who consume alcohol excessively should have liver function tests done before taking this medication, and if symptoms of liver dysfunction appear during use, they should consult a healthcare professional immediately. Since this medication can affect blood enzyme levels, regular blood tests are recommended. Pregnant women or women of childbearing potential should avoid this medication as it could pose a risk to the fetus, and must use contraception while taking it; upon confirmation of pregnancy, the medication should be stopped immediately. Breastfeeding women should also avoid taking this medication for safety reasons. The safety of this medication in children and adolescents has not been sufficiently established, hence it is not recommended for them. Elderly patients are at higher risk of myopathy, therefore caution is necessary during use, although dose adjustments are generally not required. This medication may interact with other drugs, so patients must inform their healthcare provider, especially if taking anticoagulants, fibrate class drugs, certain antibiotics, antifungals, or immunosuppressants. If symptoms such as muscle pain, weakness, changes in urine color, jaundice, severe skin rash appear during use, patients should inform medical personnel immediately. This medication may cause dizziness that could affect driving or machine operation, therefore caution is advised. In case of overdose, as there is no specific antidote, appropriate treatment according to symptoms and liver and muscle enzyme tests will be required.
Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, elevated AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased blood lactate dehydrogenase, pruritus, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, myositis, weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, cough, dyspnea, diarrhea, cold sweats, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid drooping, diabetic retinopathy, ear discomfort, renal impairment, benign esophageal neoplasm, chest pain, strange sensation, drug intolerance, irritable bowel syndrome, esophagitis, drowsiness, neurodegenerative disorders, orthostatic dizziness, migraine, glucose tolerance disorder, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, elevated serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, nausea, abdominal pain, diarrhea, chest pain, chest discomfort, systemic edema, diabetic neuropathy, tremor, upper abdominal pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival injection, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased blood urea, elevated CPK, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or humidity, so it must be stored in a tightly closed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Storing it this way ensures the safety and effectiveness of the medication.
Pink oval film-coated tablet
30 tablets/box [10 tablets/PTP * 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.